Live News EQUITY ARTICLE L impact Jul 01, 2026, 04:11 PM UTC

TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target

TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ: TMDX ) with a Buy and maintains $120 price target.

SquawkNews Newsroom

TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ: TMDX ) with a Buy and maintains $120 price target.